NIGI, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 6.278
EU - Europa 4.584
AS - Asia 2.325
SA - Sud America 299
AF - Africa 133
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 4
Totale 13.644
Nazione #
US - Stati Uniti d'America 6.209
IT - Italia 1.202
RU - Federazione Russa 1.002
SG - Singapore 783
CN - Cina 690
GB - Regno Unito 660
IE - Irlanda 556
SE - Svezia 246
BR - Brasile 241
VN - Vietnam 240
HK - Hong Kong 202
FR - Francia 176
UA - Ucraina 176
DE - Germania 165
FI - Finlandia 152
KR - Corea 105
IN - India 85
ZA - Sudafrica 80
ES - Italia 59
BD - Bangladesh 52
NL - Olanda 41
CA - Canada 35
TR - Turchia 33
BE - Belgio 29
PK - Pakistan 26
MX - Messico 23
AT - Austria 21
AU - Australia 19
PL - Polonia 19
IQ - Iraq 18
AR - Argentina 16
CZ - Repubblica Ceca 15
JP - Giappone 15
IR - Iran 12
SA - Arabia Saudita 12
GR - Grecia 11
EC - Ecuador 10
NG - Nigeria 10
CH - Svizzera 8
EG - Egitto 8
CL - Cile 7
JO - Giordania 7
LT - Lituania 7
MA - Marocco 7
KE - Kenya 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
IL - Israele 5
RO - Romania 5
AM - Armenia 4
CI - Costa d'Avorio 4
CO - Colombia 4
DZ - Algeria 4
PE - Perù 4
PY - Paraguay 4
TH - Thailandia 4
DK - Danimarca 3
ID - Indonesia 3
KG - Kirghizistan 3
LU - Lussemburgo 3
PA - Panama 3
PT - Portogallo 3
UY - Uruguay 3
UZ - Uzbekistan 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BG - Bulgaria 2
BW - Botswana 2
BY - Bielorussia 2
EU - Europa 2
GY - Guiana 2
LV - Lettonia 2
MD - Moldavia 2
MK - Macedonia 2
MY - Malesia 2
NO - Norvegia 2
PH - Filippine 2
PR - Porto Rico 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
UG - Uganda 2
AO - Angola 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
HU - Ungheria 1
IM - Isola di Man 1
JM - Giamaica 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LY - Libia 1
Totale 13.628
Città #
Dallas 1.713
Southend 557
Dublin 552
Fairfield 525
Ashburn 469
Singapore 449
Moscow 287
San Jose 260
Woodbridge 252
Chandler 251
Santa Clara 250
Houston 229
Seattle 211
Milan 208
Siena 204
Hong Kong 194
Cambridge 188
Beijing 186
Wilmington 171
Hefei 145
Jacksonville 140
Council Bluffs 120
Florence 111
New York 109
Seoul 103
Helsinki 100
Los Angeles 84
The Dalles 83
Ann Arbor 79
Johannesburg 74
Princeton 74
Rome 71
Munich 66
Lauterbourg 63
Ho Chi Minh City 60
Dong Ket 52
Hanoi 48
Nanjing 45
Málaga 40
Shanghai 39
San Diego 35
Buffalo 29
Boardman 26
San Mateo 23
São Paulo 22
London 21
Frankfurt am Main 19
Turku 19
Washington 19
Bengaluru 18
Chennai 18
Orem 18
Phoenix 18
Turin 18
Dearborn 17
Nanchang 16
Chicago 15
Columbus 15
Toronto 15
Changsha 14
Lappeenranta 14
Leuven 14
Montreal 13
Fremont 12
Nuremberg 12
Portsmouth 12
Redondo Beach 12
Warsaw 12
Brno 11
Mumbai 11
Pisa 11
Shenyang 11
Stockholm 11
Verona 11
Vienna 11
Zhengzhou 11
Amsterdam 10
Atlanta 10
Baghdad 10
Bologna 10
Boston 10
Brooklyn 10
Guangzhou 10
Karachi 10
Lahore 10
Norwalk 10
San Francisco 10
Tokyo 10
Da Nang 9
Genoa 9
Izmir 9
Jiaxing 9
Kraainem 9
Manchester 9
Mexico City 9
Dhaka 8
Enfield 8
Hangzhou 8
Istanbul 8
Redmond 8
Totale 9.669
Nome #
Comprehensive sequencing profile and functional analysis of IsomiRs in human pancreatic islets and beta cells 1.261
MicroRNA expression in the aqueous humor of patients with diabetic macular edema 333
Abnormal neutrophil signature in the blood and pancreas of presymptomatic and symptomatic type 1 diabetes 326
Acute on chronic limb ischemia: From surgical embolectomy and thrombolysis to endovascular options 319
Circulating microRNAs and diabetes mellitus: a novel tool for disease prediction, diagnosis, and staging? 305
Dapagliflozin modulates glucagon secretion in an SGLT2-independent manner in murine alpha cells 305
MicroRNAs as Regulators of Insulin Signaling: Research Updates and Potential Therapeutic Perspectives in Type 2 Diabetes 304
From immunohistological to anatomical alterations of human pancreas in type 1 diabetes: New concepts on the stage 304
Serum Levels of miR-148a and miR-21-5p Are Increased in Type 1 Diabetic Patients and Correlated with Markers of Bone Strength and Metabolism 301
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 286
Regulatory T-cells from pancreatic lymphnodes of patients with type-1 diabetes express increased levels of microRNA miR-125a-5p that limits CCR2 expression 277
MicroRNA miR-124a, a negative regulator of insulin secretion, is hyperexpressed in human pancreatic islets of type 2 diabetic patients 266
MicroRNA expression profiles of human iPSCs differentiation into insulin-producing cells 262
Islet-reactive CD8+T cell frequencies in the pancreas, but not in blood, distinguish type 1 diabetic patients from healthy donors 261
Chronic kidney disease in type 2 diabetes: Lessons from the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicentre Study 257
Clinical significance of nonalbuminuric renal impairment in type 2 diabetes 253
HbA1c Variability As an Independent Correlate of Nephropathy, but Not Retinopathy, in Patients With Type 2 Diabetes: The Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study 248
Conventional and Neo-Antigenic Peptides Presented by β Cells Are Targeted by Circulating Naïve CD8+ T Cells in Type 1 Diabetic and Healthy Donors 248
Targeting microRNAs as a Therapeutic Strategy to Reduce Oxidative Stress in Diabetes 247
MicroRNA profiling in sera of patients with type 2 diabetes mellitus reveals an upregulation of miR-31 expression in subjects with microvascular complications 244
A set of circulating microRNAs belonging to the 14q32 chromosome locus identifies two subgroups of individuals with recent-onset type 1 diabetes 238
Combination therapy with metformin plus vildagliptin in type 2 diabetes mellitus 236
Gender differences in cardiovascular disease risk factors, treatments and complications in patients with type 2 diabetes: the RIACE Italian multicentre study 228
The Landscape of microRNAs in βCell: between phenotype maintenance and protection 225
Unexpected subcellular distribution of a specific isoform of the Coxsackie and adenovirus receptor, CAR-SIV, in human pancreatic beta cells 224
Distribution of cardiovascular disease and retinopathy in patients with type 2 diabetes according to different classification systems for chronic kidney disease: a cross-sectional analysis of the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study 223
Analysis of post-transplant diabetes mellitus (PTDM) prevalence in a population of kidney transplant recipients 222
Prevention and treatment of autoimmune diseases with plant virus nanoparticles 222
Prospective Validation of ATA and ETA Sonographic Pattern Risk of Thyroid Nodules Selected for FNAC 220
Pancreatic Alpha-Cells Contribute Together With Beta-Cells to CXCL10 Expression in Type 1 Diabetes 218
Intra-islet insulin synthesis defects are associated with endoplasmic reticulum stress and loss of beta cell identity in human diabetes 215
12-Month Efficacy of Advanced Hybrid Closed-Loop System in Adult Type 1 Diabetes Patients 210
Circulating microRNAs as clinically useful biomarkers for Type 2 Diabetes Mellitus: miRNomics from bench to bedside 209
Non-coding RNAs: novel players in insulin resistance and related diseases 204
Is resistant hypertension an independent predictor of all-cause mortality in individuals with type 2 diabetes? A prospective cohort study 203
La prevenzione del diabete mellito di tipo 1 201
Circulating microRNAs signature for predicting response to GLP1-RA therapy in Type 2 diabetic patients: a pilot study 195
Increased Expression of Viral Sensor MDA5 in Pancreatic Islets and in Hormone-Negative Endocrine Cells in Recent Onset Type 1 Diabetic Donors 192
Fighting diabetic foot ulcers—The diabetologist: A king maker of the fight 190
SARS-CoV-2 receptor Angiotensin I-Converting Enzyme type 2 (ACE2) is expressed in human pancreatic β-cells and in the human pancreas microvasculature 187
The case for virus-induced type 1 diabetes 186
Reduced miR-184-3p expression protects pancreatic β-cells from lipotoxic and proinflammatory apoptosis in type 2 diabetes via CRTC1 upregulation 183
Microbioma intestinale e diabete mellito 179
Erectile dysfunction and diabetes: association with the impairment of lipid metabolism and oxidative stress. 169
Environmental factors in the development of diabetes mellitus 159
12-Month Time in Tight Range Improvement with Advanced Hybrid-Closed Loop System in Adults with Type 1 Diabetes 155
Protocol to analyze circulating small non-coding RNAs by high-throughput RNA sequencing from human plasma samples 150
Il ruolo del laboratorio nella valutazione dell'insulino-resistenza. 144
MicroRNAs: Novel players in the dialogue between pancreatic islets and immune system in autoimmune diabetes 139
The impact of environmental pollution on metabolic health and the risk of non-communicable chronic metabolic diseases in humans 138
Real-world use of oral versus subcutaneous semaglutide in a cohort of type 2 diabetic patients: which option to which patient? 138
Extracellular vesicles in immune system regulation and Type 1 diabetes: cell-to-cell communication Mediators, disease biomarkers, and promising therapeutic tools 136
CD8+ T Cells Variably Recognize Native Versus Citrullinated GRP78 Epitopes in Type 1 Diabetes 128
Maternal gluten, cereal, and dietary fiber intake during pregnancy and lactation and the risk of islet autoimmunity and type 1 diabetes in the child 118
null 114
null 109
null 106
Editorial: The contribution of viruses and innate immune system in the pathogenesis of type 1 diabetes 99
Adherence to the mediterranean diet and risk of hypoglycemia in insulin-treated type 2 diabetic patients 85
null 85
Coxsackie-adenovirus receptor expression is enhanced in pancreas from patients with type 1 diabetes 83
null 79
Hyperglycemia and diabetes induced by glucocorticoids in nondiabetic and diabetic patients: Revision of literature and personal considerations 69
Towards an Earlier and Timely Diagnosis of Type 1 Diabetes: Is it Time to Change Criteria to Define Disease Onset? 60
Totale 13.880
Categoria #
all - tutte 38.733
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.733


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022660 59 83 44 78 25 20 31 24 31 52 79 134
2022/20231.014 47 106 94 107 113 223 24 72 81 54 56 37
2023/20241.023 36 43 101 61 52 253 291 33 14 50 15 74
2024/20251.977 42 108 226 125 277 128 74 104 198 84 175 436
2025/20265.882 327 572 1.638 611 919 150 529 173 167 309 166 321
2026/202729 29 0 0 0 0 0 0 0 0 0 0 0
Totale 13.880